The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage

Kevin M. Lawrence(Jefferson Healthcare), David S. Latchman(Laboratory of Molecular Genetics), Michael Hubank(Royal Marsden Hospital), Simon Eaton(Great Ormond Street Hospital), Sean M. Davidson(University College London), Richard A. Knight(Institute of Child Health), Anastasis Stephanou(Laboratory of Molecular Genetics), Paul A. Townsend(University College London), Christopher J. Carroll(St George's, University of London)
Biochemical and Biophysical Research Communications
July 21, 2004
10.1016/j.bbrc.2004.06.170
Cited by 32

Related Papers

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in <i>PINK1</i>
|Science|2004|3.5k
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial
|BMJ|2008|769
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386
A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
|Endocrinology|2008|382